 IRVINE, Calif., June 24, 2021 GLOBE NEWSWIRE -- Biomerica Inc. NASDAQ: BMRA today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomericas new and proprietary Helicobacter pylori test, called hpdetectTM. The hpdetectTM product has been developed for the identification and monitoring of H. pylori infection, the leading cause of duodenal and gastric ulcers, and a contributing risk factor associated with gastric cancer. Physicians and medical centers can use hpdetectTM to diagnose the presence of H. pylori and to monitor the efficacy of treatment. 